View online Forward to a friend   |   Facebook   |   Twitter
American Pharmaceutical News In Review
Articles   |   Announcements   |   Videos   |   Whitepapers   |  Product Listings   |   News   |   Events
August 07, 2019
learn more
Newsletter Sponsor
  VAI’s SMA MicroParticle ICS Offers Unmatched Environmental Control

The SMA MicroParticle ICS™ Particle Counters are used for continuous or periodic monitoring of particle counts in critical environments. The instruments offer unmatched environmental control by utilizing the latest innovations in particle counting technology and by integrating several features not found in other particle counters. The instruments allow for advanced multi-processing, have complaint reporting, and are easy to configure. Integration into a facility’s current monitoring and/or management systems is seamless. Three models are available: HandHeld, TableTop, and Wall Mounted models.

more info

» Industry News
learn more
  Lilly Announces Positive Results for Emgality from CONQUER Study
Eli Lilly announced Emgality met the primary and secondary outcomes in preventive treatment of ... read more »
learn more
  FDA Approves First Therapy for Rare Joint Tumor
The FDA granted approval to Turalio capsules for adult patients with symptomatic TGCT associated ... read more »
learn more
  Provention Bio Announces Breakthrough Therapy Designation for Teplizumab
Provention Bio announced the FDA has granted Breakthrough Therapy Designation to teplizumab for the ... read more »
learn more
  Sosei Heptares, Takeda Announce Partnership
Sosei has entered into a strategic multi-target partnership with Takeda to discover, develop and ... read more »
learn more
  Altavant Sciences Initiates Study of Rodatristat Ethyl in Pulmonary Arterial Hypertension
Altavant has dosed the first patient in the ELEVATE 1 proof-of-concept Phase 2a study of rodatristat... read more »
learn more
  Bracco Diagnostics Receives FDA Approval for VARIBAR® THIN LIQUID
Bracco Diagnostics announced FDA approval for VARIBAR® THIN LIQUID for oral suspension which is ... read more »

more news
 
» Featured Articles
Pharmaceutical P.I.N. Points Patent Innovation News
The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical ... read more »
Challenges in the Downstream Process of Gene Therapy Products
Over the last few years, gene therapy (GT) has emerged as a promising medical tool to treat diseases... read more »
more articles
 
» Featured Video
learn more
  Watch Video: Sartorius Stedim Biotech Paul Priebe talks about Single-Use Technologies at Interphex 2019
Sartorius Stedim Biotech Paul Priebe Interview at Interphex 2019 read more »
learn more
  Watch Video: Interphex 2019 Wrap Up Video
Watch Video: Interphex 2019 Wrap Up Video read more »

more videos
 
» Featured Products
learn more
  Facility Monitoring System
read more »
learn more
  TruCLEAN Pro Cleaning & Disinfecting System
read more »

more products
 
» Featured Whitepaper
Wall Chart: COMPLETE SOLUTIONS FOR COMPLETE CONFIDENCE with Steritest™ System
Our expertise in sterility testing dates back over 40 years from when we invented the original Steritest closed filtration system, which changed sterility testing forever. We are raising the ... read more »
The NEXT GENERATION in Protein Characterization
The ability to measure and characterize changes in the secondary structure of proteins is critical to many research applications, especially the formulation and development of biotherapeutics. read more »

more whitepapers
 
| Events
EVENT
  SMi’s 10th Annual Biosimilars Conference
London, UK –  09/24/2019
SMi Group are delighted to announce the 10th annual Biosimilars Conference taking place on 25th and 26th September 2019. This year’s event will be our...
event details »
EVENT
  SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
London, UK –  10/15/2019
Addressing the Microbiological Aspects in Cleanroom Design and Engineering SMi Group are pleased to announce the Inaugural Pharmaceutical Cleanroom ...
event details »

more events
This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription |  Unsubscribe  | Contact American Pharmaceutical Review


American Pharmaceutical Review
395 Oyster Point Blvd, Suite 300
South San Francisco, CA 94080 USA